These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


476 related items for PubMed ID: 221518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity.
    Oelkers W.
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):91-7. PubMed ID: 2982239
    [Abstract] [Full Text] [Related]

  • 4. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [Abstract] [Full Text] [Related]

  • 5. Effect of prolonged low-dose infusions of ile5-angiotensin ii on blood pressure, aldosterone and electrolyte excretion in sodium replete man.
    Oelkers W, Schöneshöfer M, Schultze G, Bauer B.
    Klin Wochenschr; 1978 Jan 01; 56(1):37-41. PubMed ID: 628191
    [Abstract] [Full Text] [Related]

  • 6. The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man.
    Oelkers W, Belkien L, Baumann J, Meyland M.
    Clin Exp Hypertens A; 1982 Jan 01; 4(9-10):1505-17. PubMed ID: 6291811
    [Abstract] [Full Text] [Related]

  • 7. Effect of low normal and high normal sodium intake on hormonal and metabolic responses to ACTH, angiotensin II and an acute salt load in normal subjects.
    Schiffrin EL, Gutkowska J, Julesz J, Thibault G, Genest J.
    Clin Invest Med; 1984 Jan 01; 7(3):149-55. PubMed ID: 6097382
    [Abstract] [Full Text] [Related]

  • 8. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM, Vaughan ED, Peach MJ, Ayers CR.
    J Clin Invest; 1978 Jan 01; 61(1):20-31. PubMed ID: 338631
    [Abstract] [Full Text] [Related]

  • 9. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG, Espiner EA, Donald RA.
    J Lab Clin Med; 1976 Jun 01; 87(6):1005-15. PubMed ID: 180213
    [Abstract] [Full Text] [Related]

  • 10. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
    Kigoshi T, Iwasaki R, Kaneko M, Nakano S, Azukizawa S, Uchida K, Morimoto S.
    J Clin Endocrinol Metab; 1991 Jun 01; 72(6):1200-5. PubMed ID: 1851181
    [Abstract] [Full Text] [Related]

  • 11. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE.
    Circ Res; 1977 May 01; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [Abstract] [Full Text] [Related]

  • 12. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
    Cénac A, London A, Ménard J, Corvol P.
    Ann Endocrinol (Paris); 1975 May 01; 36(3):153-62. PubMed ID: 172005
    [Abstract] [Full Text] [Related]

  • 13. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J, Tree M, Brown JJ, Fraser R, Lever AF, Millar JA, Morton JJ, Robertson JI, Reid JL, Hamilton C.
    J Hypertens; 1983 Jun 01; 1(1):27-35. PubMed ID: 6397510
    [Abstract] [Full Text] [Related]

  • 14. Potassim-aldosterone-renin interrelationships.
    Himathongkam T, Dluhy RG, Williams GH.
    J Clin Endocrinol Metab; 1975 Jul 01; 41(1):153-9. PubMed ID: 1167307
    [Abstract] [Full Text] [Related]

  • 15. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM, Thorner MO, Ortt EM.
    J Clin Invest; 1979 Apr 01; 63(4):727-35. PubMed ID: 438333
    [Abstract] [Full Text] [Related]

  • 16. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Aust N Z J Med; 1976 Aug 01; 6(3 Suppl):48-52. PubMed ID: 1071403
    [Abstract] [Full Text] [Related]

  • 17. Regulation of aldosterone secretion: current concepts and newer aspects.
    Bravo EL.
    Adv Nephrol Necker Hosp; 1977 Aug 01; 7():105-20. PubMed ID: 208405
    [Abstract] [Full Text] [Related]

  • 18. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM, Williams GH, Hollenberg NK, Davies RO, Moore TJ, Dluhy RG.
    J Clin Endocrinol Metab; 1983 Oct 01; 57(4):764-70. PubMed ID: 6309884
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of inhibition of aldosterone secretion by adrenocorticotropin.
    Aguilera G, Fujita K, Catt KJ.
    Endocrinology; 1981 Feb 01; 108(2):522-8. PubMed ID: 6256154
    [Abstract] [Full Text] [Related]

  • 20. Renin-angiotensin-aldosterone system of the normothermic marmot.
    Kastner PR, Zatzman ML, South FE, Johnson JA.
    Am J Physiol; 1977 Jul 01; 233(1):R37-43. PubMed ID: 195479
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.